Sumitomo Mitsui Trust Group Inc. lessened its position in Teva Pharmaceutical Industries Limited (NYSE:TEVA – Free Report) by 0.5% in the 3rd quarter, according to its most recent filing with the SEC.

Opioid Withdrawal Treatment market Rising Trends, Demand and Future Scope 2025 to 2034 ...

In closing its therapeutics division and laying off 200 people, 23andMe ended an audacious bet it made nearly a decade ago — ...

A new generic version of varenicline – originally sold in the UK as Champix by Pfizer – has now been approved for use by the ...

This includes Emma's best-selling Emma Comfort Mattress and the cooling Emma Diamond Hybrid Mattress. As well as dresses, the sale also includes Aje's denim pieces, show-stopping party pants, and ...

Back in 2020, we spoke with actress Sasheer Zamata about the hula hoop and sandals she can’t live without. Four years later, ...

EPS, expectations were $0.66. Operator: Hello, and welcome to the Q3 2024 Teva Pharmaceuticals Industries Limited Earnings ...

Operator Hello, and welcome to the Q3 2024 Teva Pharmaceuticals Industries Limited earnings conference call. My name is Alex, ...

Teva Pharmaceutical Industries Ltd (NYSE:TEVA) reported third-quarter 2024 sales of $4.33 billion on Wednesday. It beat the ...

ACCESS HERE THE COMPLETE PRESS RELEASE TEV-?749 / mdc-TJK - Investigational Olanzapine Long-Acting Injectable Teva presented positive data from the initial period of the Phase 3 SOLARIS trial ...